SAB Biotherapeutics prices $85M stock offering at $3.85/share
#SAB Biotherapeutics #stock offering #$85 million #$3.85 per share #capital raise #biotechnology #public offering #share price
📌 Key Takeaways
- SAB Biotherapeutics priced an $85 million stock offering at $3.85 per share
- The offering aims to raise capital for the company's operations and development
- The pricing reflects the company's current market valuation and investor demand
- Proceeds will support SAB Biotherapeutics' biotech research and pipeline advancement
🏷️ Themes
Biotech Financing, Stock Offering
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
MIAMI - SAB Biotherapeutics, Inc. (NASDAQ:SABS) announced Monday the pricing of an underwritten public offering of 19,324,677 shares of common stock at $3.85 per share, according to a press release statement.
Read full article at source